What is the catalog number for Akt (Phospho-Ser473) Antibody?

The catalog number for Akt (Phospho-Ser473) Antibody is orb222951.

What sizes are available for Akt (Phospho-Ser473) Antibody?

Akt (Phospho-Ser473) Antibody is available in the following size(s): 25 µg, 50 µg, 100 µg, 200 µg.

How many pack sizes does Akt (Phospho-Ser473) Antibody come in?

Akt (Phospho-Ser473) Antibody is available in 4 different pack sizes.

Is Akt (Phospho-Ser473) Antibody in stock?

Akt (Phospho-Ser473) Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Akt (Phospho-Ser473) Antibody

Akt (Phospho-Ser473) Antibody is an unconjugated polyclonal antibody. It is suitable for use in IHC, WB. It exhibits reactivity with Human, Mouse, Rat.

Product Specifications

Product Name Alternative

Anti AKT 1 antibody, anti AKT antibody, anti AKT1 antibody, anti C AKT antibody, anti Oncogene AKT1 antibody, anti PKB antibody, anti PKB-ALPHA antibody, anti PRKBA antibody, anti Protein Kinase B Alpha antibody, anti Protein kinase B antibody, anti Proto-oncogene c-Akt antibody, anti RAC Alpha antibody, anti RAC antibody, anti RAC PK Alpha antibody, anti RAC Serine/Threonine Protein Kinase antibody, anti RAC-alpha serine/threonine-protein kinase antibody, anti RAC-PK-alpha antibody, anti vAKT Murine Thymoma Viral Oncogene Homolog 1 antibody

UniProt

P31751, P31749, Q9Y243

Reactivity

Human, Mouse, Rat

Immunogen

C-terminal

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Signal Transduction

Concentration

1mg/ml

Dilution

WB: 1:500-1:3000, IHC-P: 1:50-1:100, ELISA: 1:5000

References & Citations

Ma, Lin et al. Baicalein Protects Rats with Diabetic Cardiomyopathy Against Oxidative Stress and Inflammation Injury via Phosphatidylinositol 3-Kinase (PI3K) /AKT Pathway Med Sci Monit, 24, 5368-5375 (2018), Tao, Haitao et al. Downregulation of miR-34a Promotes Proliferation and Inhibits Apoptosis of Rat Osteoarthritic Cartilage Cells by Activating PI3K/Akt Pathway Clin Interv Aging, 15, 373-385 (2020), Xu, Dongsheng et al. miR-10a overexpression aggravates renal ischemia-reperfusion injury associated with decreased PIK3CA expression BMC Nephrol, 21, 248 (2020)